Me could be back in the hands of former CEO Anne Wojcicki after her nonprofit offered $305 million to buy the company.

Anne Wojcicki is set to regain control of 23andMe after a nonprofit she controls topped Regeneron Pharmaceuticals' bid for ...

Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron ...

Twenty-seven states and the District of Columbia have sued the bankrupt genetic testing company 23andMe in an effort to block ...

The genetic-testing company, which collected DNA data from users, is for sale in bankruptcy court. Now, 27 states and the ...

As 23andMe works to climb out of bankruptcy through a massive sale, customers are worried their DNA is being offered to the ...

The genetic testing company 23andMe is poised to be sold to a nonprofit run by the company's former chief executive Anne ...

Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a ...

The co-founder of bankrupt genetic analysis company 23andMe won an auction for the firm’s assets, agreeing, along with a ...

A growing number of 23andMe users are distancing themselves from the once-popular genetic testing company, as mounting ...

House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...

An independent privacy official will oversee 23andMe’s proposed sale after Illinois and 26 other states raised concerns about ...